Autoinjectors Market

Autoinjectors Market (Type: Disposable and Reusable; Technology: Handheld and Wearable; Indication: Multiple Sclerosis, Rheumatoid Arthritis, Diabetes, Anaphylaxis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Autoinjectors Market Outlook 2031

  • The global industry was valued at US$ 1.0 Bn in 2022
  • It is projected to advance at a CAGR of 16.2% from 2023 to 2031 and reach more than US$ 3.8 Bn by the end of 2031

Analysts’ Viewpoint

Increase in prevalence of chronic diseases is driving the global autoinjectors market. Conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, and autoimmune diseases require frequent and precise administration of medications. Shift toward self-care and home healthcare has propelled demand for autoinjectors. Surge in incidence of anaphylaxis and severe allergic reactions has fueling demand for autoinjectors, particularly for epinephrine administration. Furthermore, ease of use and accuracy offered by autoinjectors are expected to propel market expansion during the forecast period.

Technological advancements in autoinjector devices offer lucrative opportunities to market players. Manufacturers are continually investing in research & development to improve the functionality, usability, and safety features of autoinjectors.

Autoinjectors Market

Global Autoinjectors Market Introduction

Autoinjectors are devices designed to deliver a specific dose of medication to patients with ease and precision. These are typically used for self-administration of medications, and offer advantages such as convenience, accuracy, and reduced needlestick injuries.

Autoinjectors have witnessed substantial developments, including integration of electronic features such as dose memory, connectivity, and audio-visual guidance, enhancing patient adherence and monitoring.

Manufacturers are focusing on user-friendly designs, ergonomic features, and improvements in needle safety mechanisms to ensure patient comfort and safety. Moreover, advancements in technology have led to the development of smart autoinjectors capable of wirelessly transmitting data to healthcare providers for monitoring and tracking purposes.

Rise in prevalence of chronic diseases has led to a shift toward self-care and increase in demand for home healthcare. These factors are likely to propel global autoinjectors market size during the forecast periods.

Rise in Prevalence of Chronic Diseases and Allergic Conditions

Rise in prevalence of chronic diseases such as diabetes, rheumatoid arthritis, multiple sclerosis, and autoimmune disorders necessitates regular medication administration. This has increased demand for autoinjectors as a convenient and user-friendly method for patients to self-administer their medications, reducing their reliance on healthcare professionals and improving their overall quality of life.

The portable nature and ease of use of autoinjectors make them particularly beneficial for individuals who require frequent injections, allowing them to administer their medication conveniently at home or while on the move.

Prevalence of allergic conditions, including severe allergies and anaphylaxis, has also contributed to the surge in global autoinjectors market demand. Anaphylaxis is a potentially life-threatening allergic reaction that requires immediate administration of epinephrine (adrenaline). Autoinjectors, such as EpiPens, are specifically designed to deliver precise dose of epinephrine during an anaphylactic emergency.

Increase in awareness about anaphylaxis and the importance of timely treatment has induced individuals with allergies and their caregivers to opt for autoinjectors as a crucial tool in managing and responding to allergic reactions.

Advancements in Technology

Advancements in technology are expected to drive the global auto injectable market value by revolutionizing the way injectable medications are administered. These advancements encompass various aspects, including device design, connectivity, usability, and safety features These are aimed at improving patient experience and treatment outcomes.

Device design is one key area of advancement. Manufacturers are continuously innovating to create more user-friendly and intuitive autoinjectors. This involves optimizing the ergonomics of the device, simplifying the injection process, and ensuring accurate dosage delivery. For instance, autoinjectors now feature improved grip designs, ergonomic buttons, and clear visual indicators to facilitate easy and precise administration.

Connectivity is another crucial aspect driving market development. With the integration of digital technologies, autoinjectors can now connect to mobile applications and healthcare platforms, enabling remote monitoring, data collection, and personalized treatment management. Patients can receive reminders, track their injections, and share data with healthcare providers, leading to better treatment adherence and disease management.

Usability enhancements have also played a significant role in propelling the market. Autoinjectors now incorporate features such as audio-visual prompts, systematic instructions, and feedback mechanisms to guide patients through the injection process. These user-friendly features improve patient confidence, especially for individuals who may have limited experience with self-administration.

Safety is a paramount concern, and technological advancements have addressed this by incorporating various safety features in autoinjectors. Needlestick injuries are minimized through mechanisms such as automatic needle retraction or needle shields, reducing the risk of accidental pricks. Some devices also include sensors to detect correct needle placement and prevent injection if not positioned correctly, ensuring precise and safe delivery of medication.

Convenience and Simplicity Fueling Disposable Autoinjectors Segment

In terms of type, the disposable autoinjectors segment accounted for the largest global autoinjectors market share in 2022. This is ascribed to several key factors. Disposable autoinjectors offer convenience and simplicity to both patients and healthcare providers.

These devices are pre-filled with a specific dose of medication, eliminating the need for manual loading or measurement. Patients can easily self-administer their medication without the hassle of handling needles, drawing up doses, or dealing with vials and syringes. This simplicity makes disposable autoinjectors highly preferred, especially for individuals who may have limited experience or dexterity in medication administration.

Disposable autoinjectors provide enhanced safety features. These are designed to be single-use devices, ensuring sterility and minimizing the risk of contamination or needlestick injuries. Once the medication is administered, the autoinjector is discarded, eliminating the need for needle disposal or cleaning procedure.

Slower and More Controlled Absorption of Medication Bolstering Subcutaneous Segment

Based on route of administration, the subcutaneous segment dominated the global market in 2022. Subcutaneous administration is widely used for the delivery of various medications, including biologics, hormones, and vaccines.

Several therapeutic agents are designed to be administered into the subcutaneous tissue layer, which allows for slower and more controlled absorption into the bloodstream. Autoinjectors specifically designed for subcutaneous injection provide a convenient and effective method for patients to self-administer these medications at home or in clinical settings.

The subcutaneous route offers advantages in terms of bioavailability and pharmacokinetics. Several medications are optimally absorbed and have predictable pharmacokinetic profiles when administered subcutaneously.

Autoinjectors provide consistent and accurate delivery of medication into the subcutaneous tissue, ensuring reliable absorption and maintaining therapeutic drug levels over a prolonged period.

Rise in Prevalence of Anaphylaxis

In terms of application, the anaphylaxis segment accounted for the leading share of the global autoinjectors market. Anaphylaxis is a severe and potentially life-threatening allergic reaction that necessitates immediate administration of epinephrine.

Autoinjectors have become the established method for delivering epinephrine during an anaphylactic emergency, making them an indispensable tool in managing this condition.

Prevalence of anaphylaxis is a growing global health concern. Incidence of severe allergic reactions is increasing, with a growing number of individuals being diagnosed with allergies to various triggers such as foods, insect stings, medications, and more. Consequently, demand for autoinjectors to effectively treat anaphylaxis is witnessing significant rise in the market.

Extensive Usage of Autoinjectors in Hospitals & Clinics

Based on end-user, the hospitals & clinics segment dominated the global market in 2022. Autoinjectors are extensively used in hospitals and clinics for various purposes, including the administration of medications for chronic diseases, emergency treatments, and vaccinations. Availability of skilled healthcare professionals in these settings ensures proper training and supervision for patients who require assistance in using autoinjectors.

Hospitals and clinics have well-established infrastructure and resources to support the utilization of autoinjectors. These facilities are equipped with medical professionals, including doctors, nurses, and pharmacists, who play a critical role in prescribing, dispensing, and administering medications via autoinjectors.

Hospitals and clinics have proper storage facilities and inventory management systems to handle the stock of autoinjectors and ensure their availability when needed.

Regional Outlook of Global Autoinjectors Market

North America benefits from a strong healthcare infrastructure and high prevalence of chronic diseases. Increase in incidence of conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, and autoimmune disorders in the region has led to higher demand for self-administered injectable medications.

Europe has witnessed advancements in technology and innovation in the field of autoinjectors. Manufacturers in the region are continually investing in research and development to enhance product features, usability, and patient experience.

Introduction of user-friendly designs, needle safety mechanisms, and electronic monitoring systems has improved the overall functionality and acceptance of autoinjectors. These technological advancements are propelling the autoinjectors market in Europe.

Government initiatives and policies focused on improving healthcare infrastructure and access to medical technologies have contributed to the growth of the autoinjectors market in Asia Pacific. Governments in countries such as China and India are investing in healthcare reforms, which include the expansion of healthcare facilities and the promotion of self-care practices. Such initiatives create a conducive environment for the adoption of autoinjectors and drive market growth.

Analysis of Key Players

The global market is fragmented, with the presence of a number of players. Leading players have adopted strategies such new product development and merger & expansion in order to increase market presence. Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan N.V., Amgen, Inc., SHL Medical AG, and Recipharm AB are the prominent players in the market.

Key Developments in Global Autoinjectors Industry

  • In May 2022, Jabil Healthcare, a division of Jabil, Inc., introduced the Qfinity autoinjector platform, a cost-effective solution for subcutaneous drug self-administration that emphasizes sustainability in the pharmaceutical industry. With the growing emphasis on sustainable drug delivery, Jabil Healthcare's Qfinity autoinjector platform meets the emerging demand for environmentally-friendly solutions within the pharmaceutical sector.
  • In October 2022, Ypsomed created an advanced autoinjector platform designed specifically for liquid medications in the volume range of 1.5 ml to 5.5 ml. The YpsoMate 5.5, the newest member of the expanding YpsoMate device family, builds upon the proven technology utilized in the YpsoMate 2.25 Pro model.

The autoinjectors market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Autoinjectors Market Snapshot

Attribute Detail

Size in 2022

US$ 1.0 Bn

Forecast Value in 2031

More than US$ 3.8 Bn

CAGR - 2022-2031

16.2%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Type
    • Disposable
    • Reusable
  • Technology
    • Handheld
    • Wearable
  • Route of Administration
    • Subcutaneous
    • Intramuscular
  • Indication
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Diabetes
    • Anaphylaxis
    • Others (oncology, immunology, etc.)
  • End-user
    • Homecare Settings
    • Hospitals & Clinics

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • France
  • Germany
  • U.K.
  • Italy
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Ypsomed Holding AG
  • Novartis AG
  • BD
  • Medmix Healthcare
  • Eli Lilly and Company
  • Sanofi
  • Mylan N.V.
  • Amgen, Inc.
  • SHL Medical AG
  • Recipharm AB

Customization Scope

  • Available upon request

Pricing

  • Available upon request

Frequently Asked Questions

How big was the global autoinjectors market in 2022?

The global industry was valued at US$ 1.0 Bn in 2022

How big will be the autoinjectors industry in 2031?

It is projected to reach more than US$ 3.8 Bn by 2031

What will be the CAGR of the global autoinjectors business during the forecast period?

The industry is likely to advance at a CAGR of 16.2% from 2023 to 2031

Which region will account for major market share of the autoinjectors during the forecast period?

North America is expected to account for largest share from 2022 to 2031

Who are the prominent autoinjectors players?

Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan N.V., Amgen, Inc., SHL Medical AG, and Recipharm AB are the prominent players in the market

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Autoinjectors Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Autoinjectors Market Analysis and Forecast, 2017-2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancement

    5.2. Disease Incidence and Prevalence

    5.3. Overview: Future of Autoinjectors

    5.4. Regulatory Analysis

    5.5. COVID-19 Impact Analysis

6. Global Autoinjectors Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017-2031

        6.3.1. Disposable

        6.3.2. Reusable

    6.4. Market Attractiveness Analysis, by Type

7. Global Autoinjectors Market Analysis and Forecast, by Technology

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Technology, 2017-2031

        7.3.1. Handheld

        7.3.2. Wearable

    7.4. Market Attractiveness Analysis, by Technology

8. Global Autoinjectors Market Analysis and Forecast, by Route of Administration

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Route of Administration, 2017-2031

        8.3.1. Subcutaneous

        8.3.2. Intramuscular

    8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Autoinjectors Market Analysis and Forecast, by Indication

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by Indication, 2017-2031

        9.3.1. Multiple Sclerosis

        9.3.2. Rheumatoid Arthritis

        9.3.3. Diabetes

        9.3.4. Anaphylaxsis

        9.3.5. Others

    9.4. Market Attractiveness Analysis, by Indication

10. Global Autoinjectors Market Analysis and Forecast, by End-user

    10.1. Introduction & Definition

    10.2. Key Findings / Developments

    10.3. Market Value Forecast, by End-user, 2017-2031

        10.3.1. Homecare Settings

        10.3.2. Hospitals & Clinics

    10.4. Market Attractiveness Analysis, by End-user

11. Global Autoinjectors Market Analysis and Forecast, by Region

    11.1. Key Findings

    11.2. Market Value Forecast, by Region

        11.2.1. North America

        11.2.2. Europe

        11.2.3. Asia Pacific

        11.2.4. Latin America

        11.2.5. Middle East & Africa

    11.3. Market Attractiveness Analysis, by Region

12. North America Autoinjectors Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017-2031

        12.2.1. Disposable

        12.2.2. Reusable

    12.3. Market Value Forecast, by Technology, 2017-2031

        12.3.1. Handheld

        12.3.2. Wearable

    12.4. Market Value Forecast, by Route of Administration, 2017-2031

        12.4.1. Subcutaneous

        12.4.2. Intramuscular

    12.5. Market Value Forecast, by Indication, 2017-2031

        12.5.1. Multiple Sclerosis

        12.5.2. Rheumatoid Arthritis

        12.5.3. Diabetes

        12.5.4. Anaphylaxsis

        12.5.5. Others

    12.6. Market Value Forecast, by End-user, 2017-2031

        12.6.1. Homecare Settings

        12.6.2. Hospitals & Clinics

    12.7. Market Value Forecast, by Country, 2017-2031

        12.7.1. U.S.

        12.7.2. Canada

    12.8. Market Attractiveness Analysis

        12.8.1. By Type

        12.8.2. By Technology

        12.8.3. By Route of Administration

        12.8.4. By Indication

        12.8.5. By End-user

        12.8.6. By Country

13. Europe Autoinjectors Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Type, 2017-2031

        13.2.1. Disposable

        13.2.2. Reusable

    13.3. Market Value Forecast, by Technology, 2017-2031

        13.3.1. Handheld

        13.3.2. Wearable

    13.4. Market Value Forecast, by Route of Administration, 2017-2031

        13.4.1. Subcutaneous

        13.4.2. Intramuscular

    13.5. Market Value Forecast, by Indication, 2017-2031

        13.5.1. Multiple Sclerosis

        13.5.2. Rheumatoid Arthritis

        13.5.3. Diabetes

        13.5.4. Anaphylaxsis

        13.5.5. Others

    13.6. Market Value Forecast, by End-user, 2017-2031

        13.6.1. Homecare Settings

        13.6.2. Hospitals & Clinics

    13.7. Market Value Forecast, by Country/Sub-region, 2017-2031

        13.7.1. Germany

        13.7.2. U.K.

        13.7.3. France

        13.7.4. Italy

        13.7.5. Spain

        13.7.6. Rest of Europe

    13.8. Market Attractiveness Analysis

        13.8.1. By Type

        13.8.2. By Technology

        13.8.3. By Route of Administration

        13.8.4. By Indication

        13.8.5. By End-user

        13.8.6. By Country/Sub-region

14. Asia Pacific Autoinjectors Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Type, 2017-2031

        14.2.1. Disposable

        14.2.2. Reusable

    14.3. Market Value Forecast, by Technology, 2017-2031

        14.3.1. Handheld

        14.3.2. Wearable

    14.4. Market Value Forecast, by Route of Administration, 2017-2031

        14.4.1. Subcutaneous

        14.4.2. Intramuscular

    14.5. Market Value Forecast, by Indication, 2017-2031

        14.5.1. Multiple Sclerosis

        14.5.2. Rheumatoid Arthritis

        14.5.3. Diabetes

        14.5.4. Anaphylaxsis

        14.5.5. Others

    14.6. Market Value Forecast, by End-user, 2017-2031

        14.6.1. Homecare Settings

        14.6.2. Hospitals & Clinics

    14.7. Market Value Forecast, by Country/Sub-region, 2017-2031

        14.7.1. China

        14.7.2. Japan

        14.7.3. India

        14.7.4. Australia & New Zealand

        14.7.5. Rest of Asia Pacific

    14.8. Market Attractiveness Analysis

        14.8.1. By Type

        14.8.2. By Route of Administration

        14.8.3. By Technology

        14.8.4. By Indication

        14.8.5. By End-user

        14.8.6. By Country/Sub-region

15. Latin America Autoinjectors Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Type, 2017-2031

        15.2.1. Disposable

        15.2.2. Reusable

    15.3. Market Value Forecast, by Technology, 2017-2031

        15.3.1. Handheld

        15.3.2. Wearable

    15.4. Market Value Forecast, by Route of Administration, 2017-2031

        15.4.1. Subcutaneous

        15.4.2. Intramuscular

    15.5. Market Value Forecast, by Indication, 2017-2031

        15.5.1. Multiple Sclerosis

        15.5.2. Rheumatoid Arthritis

        15.5.3. Diabetes

        15.5.4. Anaphylaxsis

        15.5.5. Others

    15.6. Market Value Forecast, by End-user, 2017-2031

        15.6.1. Homecare Settings

        15.6.2. Hospitals & Clinics

    15.7. Market Value Forecast, by Country/Sub-region, 2017-2031

        15.7.1. Brazil

        15.7.2. Mexico

        15.7.3. Rest of Latin America

    15.8. Market Attractiveness Analysis

        15.8.1. By Type

        15.8.2. By Technology

        15.8.3. By Route of Administration

        15.8.4. By Indication

        15.8.5. By End-user

        15.8.6. By Country/Sub-region

16. Middle East & Africa Autoinjectors Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Market Value Forecast, by Type, 2017-2031

        16.2.1. Disposable

        16.2.2. Reusable

    16.3. Market Value Forecast, by Technology, 2017-2031

        16.3.1. Handheld

        16.3.2. Wearable

    16.4. Market Value Forecast, by Route of Administration, 2017-2031

        16.4.1. Subcutaneous

        16.4.2. Intramuscular

    16.5. Market Value Forecast, by Indication, 2017-2031

        16.5.1. Multiple Sclerosis

        16.5.2. Rheumatoid Arthritis

        16.5.3. Diabetes

        16.5.4. Anaphylaxsis

        16.5.5. Others

    16.6. Market Value Forecast, by End-user, 2017-2031

        16.6.1. Homecare Settings

        16.6.2. Hospitals & Clinics

    16.7. Market Value Forecast, by Country/Sub-region, 2017-2031

        16.7.1. GCC Countries

        16.7.2. South Africa

        16.7.3. Rest of Middle East & Africa

    16.8. Market Attractiveness Analysis

        16.8.1. By Type

        16.8.2. By Technology

        16.8.3. By Route of Administration

        16.8.4. By Indication

        16.8.5. By End-user

        16.8.6. By Country/Sub-region

17. Competition Landscape

    17.1. Market Player - Competition Matrix (By Tier and Size of companies)

    17.2. Market Share Analysis By Company (2022)

    17.3. Company Profiles

        17.3.1. Ypsomed Holding AG

            17.3.1.1. Company Overview

            17.3.1.2. Financial Overview

            17.3.1.3. Product Portfolio

            17.3.1.4. Business Strategies

            17.3.1.5. Recent Developments

        17.3.2. Novartis AG

            17.3.2.1. Company Overview

            17.3.2.2. Financial Overview

            17.3.2.3. Product Portfolio

            17.3.2.4. Business Strategies

            17.3.2.4. Recent Developments

        17.3.3. BD

            17.3.3.1. Company Overview

            17.3.3.2. Financial Overview

            17.3.3.3. Product Portfolio

            17.3.3.4. Business Strategies

            17.3.3.5. Recent Developments

        17.3.4. Medmix Healthcare

            17.3.4.1. Company Overview

            17.3.4.2. Financial Overview

            17.3.4.3. Product Portfolio

            17.3.4.4. Business Strategies

            17.3.4.5. Recent Developments

        17.3.5. Eli Lilly and Company

            17.3.5.1. Company Overview

            17.3.5.2. Financial Overview

            17.3.5.3. Product Portfolio

            17.3.5.4. Business Strategies

            17.3.5.5. Recent Developments

        17.3.6. Sanofi

            17.3.6.1. Company Overview

            17.3.6.2. Financial Overview

            17.3.6.3. Product Portfolio

            17.3.6.4. Business Strategies

            17.3.6.5. Recent Developments

        17.3.7. Mylan N.V.

            17.3.7.1. Company Overview

            17.3.7.2. Financial Overview

            17.3.7.3. Product Portfolio

            17.3.7.4. Business Strategies

            17.3.7.5. Recent Developments

        17.3.8. Amgen Inc.

            17.3.8.1. Company Overview

            17.3.8.2. Financial Overview

            17.3.8.3. Product Portfolio

            17.3.8.4. Business Strategies

            17.3.8.5. Recent Developments

        17.3.9. SHL Medical AG

            17.3.9.1. Company Overview

            17.3.9.2. Financial Overview

            17.3.9.3. Product Portfolio

            17.3.9.4. Business Strategies

            17.3.9.5. Recent Developments

        17.3.10. Recipharm AB

            17.3.10.1. Company Overview

            17.3.10.2. Financial Overview

            17.3.10.3. Product Portfolio

            17.3.10.4. Business Strategies

            17.3.10.5. Recent Developments

List of Tables

Table 01: Global Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031

Table 02: Global Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031

Table 03: Global Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 04: Global Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031

Table 05: Global Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 06: Global Autoinjectors Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 07: North America Autoinjectors Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 08: North America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031

Table 09: North America Autoinjectors Market (US$ Mn) Forecast, by Technology, 2017-2031

Table 10: North America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 11: North America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031

Table 12: North America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 13: Europe Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031

Table 15: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031

Table 16: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 17: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031

Table 18: Europe Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 19: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 20: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031

Table 21: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031

Table 22: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 23: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031

Table 24: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 25: Latin America Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 26: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031

Table 27: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Technology 2017-2031

Table 28: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 29: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031

Table 30: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 31: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 32: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031

Table 33: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031

Table 34: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 35: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031

Table 36: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: Global Autoinjectors Market Value Share, by Type, 2022

Figure 03: Global Autoinjectors Market Value Share, by Technology, 2022

Figure 04: Global Autoinjectors Market Value Share, by Indication, 2022

Figure 05: Global Autoinjectors Market Value Share, by Route of Administration, 2022

Figure 06: Global Autoinjectors Market Value Share, by End-user, 2022

Figure 07: Global Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031

Figure 08: Global Autoinjectors Market Revenue (US$ Mn), by Disposable, 2017-2031

Figure 09: Global Autoinjectors Market Revenue (US$ Mn), by Reusable, 2017-2031

Figure 10: Global Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 11: Global Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031

Figure 12: Global Autoinjectors Market Revenue (US$ Mn), by Handheld, 2017-2031

Figure 13: Global Autoinjectors Market Revenue (US$ Mn), by Wearable, 2017-2031

Figure 14: Global Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031

Figure 15: Global Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 16: Global Autoinjectors Market Revenue (US$ Mn), by Subcutaneous, 2017-2031

Figure 17: Global Autoinjectors Market Revenue (US$ Mn), by Intramuscular, 2017-2031

Figure 18: Global Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 19: Global Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031

Figure 20: Global Autoinjectors Market Revenue (US$ Mn), by Multiple Sclerosis, 2017-2031

Figure 21: Global Autoinjectors Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2017-2031

Figure 22: Global Autoinjectors Market Revenue (US$ Mn), by Diabetes, 2017-2031

Figure 23: Global Autoinjectors Market Revenue (US$ Mn), by Anaphylaxsis, 2017-2031

Figure 24: Global Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031

Figure 25: Global Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031

Figure 26: Global Autoinjectors Market Value Share Analysis, by Homecare Settings, 2022 and 2031

Figure 27: Global Autoinjectors Market Value Share Analysis, by Hospitals & Clinics, 2022 and 2031

Figure 28: Global Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 29: North America Autoinjectors Market Value Share Analysis, by Country, 2022 and 2031

Figure 30: North America Autoinjectors Market Attractiveness Analysis, by Country, 2023-2031

Figure 31: North America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031

Figure 32: North America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 33: North America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031

Figure 34: North America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031

Figure 35: North America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 36: North America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 37: North America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031

Figure 38: North America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031

Figure 39: North America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031

Figure 40: North America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 41: Europe Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031

Figure 42: Europe Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 43: Europe Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 44: Europe Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031

Figure 45: Europe Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 46: Europe Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031

Figure 47: Europe Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031

Figure 48: Europe Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 49: Europe Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 50: Europe Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031

Figure 51: Europe Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031

Figure 52: Europe Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031

Figure 53: Europe Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 54: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031

Figure 55: Asia Pacific Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 56: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 57: Asia Pacific Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031

Figure 58: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 59: Asia Pacific Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031

Figure 60: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031

Figure 61: Asia Pacific Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 62: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 63: Asia Pacific Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031

Figure 64: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031

Figure 65: Asia Pacific Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031

Figure 66: Asia Pacific Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 67: Latin America Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031

Figure 68: Latin America Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 69: Latin America Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 70: Latin America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031

Figure 71: Latin America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 72: Latin America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031

Figure 73: Latin America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031

Figure 74: Latin America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 75: Latin America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 76: Latin America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031

Figure 77: Latin America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031

Figure 78: Latin America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031

Figure 79: Latin America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 80: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031

Figure 81: Middle East and Africa Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 82: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 83: Middle East and Africa Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031

Figure 84: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031

Figure 85: Middle East and Africa Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031

Figure 86: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031

Figure 87: Middle East and Africa Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 88: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 89: Middle East and Africa Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031

Figure 90: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031

Figure 91: Middle East and Africa Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031

Figure 92: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031

Figure 93: Company Share Analysis, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved